The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of gedatolisib (geda) pharmacokinetics (PK), drug-drug interactions (DDI), and exposure-safety and exposure-efficacy relationships.
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; Olema Oncology (Inst); PIERRE FABRE; Puma Biotechnology
Research Funding - Amgen (Inst); AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Accord Healthcare; AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Sara Hurvitz
Stock and Other Ownership Interests - ROM Tech (I)
Research Funding - Ambryx (Inst); Amgen (Inst); Arvinas (Inst); AstraZeneca/Daiichi Sankyo (Inst); Bayer (Inst); Biomarin (Inst); Cascadian Therapeutics (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Dantari (Inst); Dignitana (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Greenwich LifeSciences (Inst); Immunomedics (Inst); Lilly (Inst); Loxo/Lilly (Inst); Macrogenics (Inst); Merrimack (Inst); Novartis (Inst); Orinove (Inst); Orum (Inst); Pfizer (Inst); Phoenix Molecular Designs (Inst); Pieris Pharmaceuticals (Inst); Puma Biotechnology (Inst); Radius Health (Inst); Samumed (Inst); sanofi (Inst); Seagen (Inst); Stemline/Menarini (Inst); Zymeworks (Inst)
Other Relationship - BeiGene (Inst); BMS (Inst); Boehringer Ingelheim; Briacell (Inst); BridgeBio Pharma (Inst); Celcuity; Embiosys; Gilead Sciences (Inst); InClin/Atossa; Jazz Pharmaceuticals (Inst); Luminate (Inst); Medsir; Mersana (Inst); Novartis; Pfizer; Roche; Roche (Inst)
 
Laura Gunn
Employment - Adaptimmune; Celcuity
Stock and Other Ownership Interests - adaptimmune; celcuity
 
Alex Cacovean
Employment - Celcuity
 
Prabhu Rajagopalan
Employment - Celcuity
 
Igor Gorbatchevsky
Employment - Celcuity
 
Sweha Patel
Employment - Intercept Pharmaceuticals